LAYTON; Mark E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LAYTON; Mark E..The latest application filed is for "hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity in voltage-gated sodium channels".

Company Profile

11.35.51

LAYTON; Mark E. - West Point PA US
Layton; Mark E. - Harleysville PA
Layton; Mark E. - Harlcysville PA
Layton; Mark E. - Barleyeville PA
Layton, Mark E. - North Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hydroxypyrrolidine-substituted Arylsulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20220305035 - Roecker; Anthony J. ; et al.	2022-09-29
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors App 20220289710 - Arasappan; Ashok ; et al.	2022-09-15
2-amino-n-heteroaryl-nicotinamides as Na.sub.v1.8 inhibitors Grant 11,377,438 - Arasappan , et al. July 5, 2	2022-07-05
2-amino-n-phenyl-nicotinamides As Nav1.8 Inhibitors App 20220119363 - Breslin; Michael J. ; et al.	2022-04-21
4-amino Or 4-alkoxy-substituted Aryl Sulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20220000844 - Bungard; Christopher J. ; et al.	2022-01-06
2-oxoimidazolidine-4-carboxamides As Nav1.8 Inhibitors App 20210403457 - Arasappan; Ashok ; et al.	2021-12-30
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors App 20210387966 - Arasappan; Ashok ; et al.	2021-12-16
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels Grant 10,968,210 - Greshock , et al. April 6, 2	2021-04-06
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors App 20200140411 - Arasappan; Ashok ; et al.	2020-05-07
Diamino-alkylamino-linked Arylsulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20200131167 - Greshock; Thomas J. ; et al.	2020-04-30
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels Grant 10,519,147 - Greshock , et al. Dec	2019-12-31
N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channels Grant 10,442,778 - Roecker , et al. Oc	2019-10-15
N1-phenylpropane-1,2-diamine Compounds With Selective Activity In Voltage-gated Sodium Channels App 20190092738 - Roecker; Anthony J. ; et al.	2019-03-28
DIAMINO-ALKYLAMINO-Linked ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS App 20180362518 - Greshock; Thomas J. ; et al.	2018-12-20
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels Grant 9,624,208 - Pero , et al. April 18, 2	2017-04-18
Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels Grant 9,586,968 - Layton , et al. March 7, 2	2017-03-07
Bicycloamine-substituted-n-benzenesulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20170002008 - Layton; Mark E. ; et al.	2017-01-05
N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels Grant 9,388,179 - Pero , et al. July 12, 2	2016-07-12
Imidazopyridin-2-one derivatives Grant 9,315,518 - Fiji , et al. April 19, 2	2016-04-19
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels Grant 9,273,040 - Layton , et al. March 1, 2	2016-03-01
N-substituted Indazole Sulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20150284389 - Pero; Joseph E. ; et al.	2015-10-08
Benzoxazolinone Compounds With Selective Activity In Voltage-gated Sodium Channels App 20150252034 - Pero; Joseph E. ; et al.	2015-09-10
Positive allosteric modulators of mGluR2 Grant 9,108,937 - Layton , et al. August 18, 2	2015-08-18
Pyrimidine PDE10 inhibitors Grant 9,062,059 - Cox , et al. June 23, 2	2015-06-23
Positive allosteric modulators of MGLUR2 Grant 8,993,779 - Dudkin , et al. March 31, 2	2015-03-31
Substituted 1,3-benzothiazol-2(3H)-ones and [1,3]thiazolo[5,4-B]pyridin-2(1H)-ones as positive allosteric modulators of mGluR2 Grant 8,952,005 - Layton , et al. February 10, 2	2015-02-10
Imidazopyridin-2-one Derivatives App 20140350002 - Fiji; Hannah D. ; et al.	2014-11-27
Benzoxazolinone Compounds With Selective Activity In Voltage-gated Sodium Channels App 20140303143 - Layton; Mark E. ; et al.	2014-10-09
Pyrimidine Pde10 Inhibitors App 20140228368 - Cox; Christopher D. ; et al.	2014-08-14
Positive allosteric modulators of MGLUR2 Grant 8,765,784 - Arrington , et al. July 1, 2	2014-07-01
Substituted 1,3-benzothiazol-2(3h)-ones And [1,3]thiazolo[5,4-b]pyridin-2(1h)-ones As Positive Allosteric Modulators Of Mglur2 App 20140045829 - LAYTON; MARK E. ; et al.	2014-02-13
Inhibitors of AKT activity Grant 8,536,193 - Furuyama , et al. September 17, 2	2013-09-17
Positive Allosteric Modulators Of Mglur2 App 20130210768 - Arrington; Kenneth L. ; et al.	2013-08-15
Isoindoline Pde10 Inhibitors App 20130203756 - Bunda; Jamie L. ; et al.	2013-08-08
Combination cancer therapy with an AKT inhibitor and other anticancer agents Grant 8,481,503 - Layton , et al. July 9, 2	2013-07-09
Positive Allosteric Modulators Of Mglur2 App 20130158002 - Layton; Mark E. ; et al.	2013-06-20
Positive Allosteric Modulators Of Mglur2 App 20130143880 - Dudkin; Vadim Y. ; et al.	2013-06-06
Substituted 1,3-Benzothiazol-2(3H)-Ones and [1,3]Thiazolo[5,4-B]Pyridin-2(IH)-Ones as Positive Allosteric Modulators of MGLUR2 App 20130035332 - Layton; Mark E. ; et al.	2013-02-07
Substituted naphthyridine compounds as inhibitors of Akt activity Grant 8,288,407 - Kelly, III , et al. October 16, 2	2012-10-16
Inhibitors Of Akt Activity App 20120252806 - Kelly, III; Michael J. ; et al.	2012-10-04
Substituted [1,2,4]triazolo[4',3':1,6]pyrido[2,3-b]pyrazines of the formula D Grant 8,207,169 - Furuyama , et al. June 26, 2	2012-06-26
Inhibitors of AKT activity Grant 8,168,652 - Sanderson , et al. May 1, 2	2012-05-01
Combination Cancer Therapy with an AKT Inhibitor and Other Anticancer Agents App 20110319354 - Layton; Mark E. ; et al.	2011-12-29
Inhibitors Of Akt Activity App 20110319443 - Sanderson; Philip E. ; et al.	2011-12-29
Inhibitors of AKT Activity App 20110288090 - Armstrong; Donna J. ; et al.	2011-11-24
Inhibitors of akt activtiy Grant 8,008,317 - Armstrong , et al. August 30, 2	2011-08-30
Inhibitors Of Akt Activity App 20110160183 - Kelly, III; Michael J. ; et al.	2011-06-30
Inhibitors Of Akt Activity App 20110092511 - Furuyama; Hidetomo ; et al.	2011-04-21
Inhibitors Of Akt Activity App 20110082135 - Furuyama; Hidetomo ; et al.	2011-04-07
Inhibitors of Akt activity Grant 7,910,561 - Arruda , et al. March 22, 2	2011-03-22
Inhibitors of akt activtiy App 20100222321 - Armstrong; Donna J. ; et al.	2010-09-02
Inhibitors Of Akt Activity App 20100022573 - Layton; Mark E. ; et al.	2010-01-28
Inhibitors Of Akt Activity App 20090253734 - Kelly, III; Michael J. ; et al.	2009-10-08
Inhibitors of Akt activity Grant 7,589,068 - Cosford , et al. September 15, 2	2009-09-15
Inhibitors of Akt activity Grant 7,576,209 - Kelly, III , et al. August 18, 2	2009-08-18
N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists App 20090124600 - Layton; Mark E.	2009-05-14
Inhibitors of Akt Activity App 20080287457 - Arruda; Jeannie M. ; et al.	2008-11-20
4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists Grant 7,452,893 - Thompson , et al. November 18, 2	2008-11-18
Inhibitors of Akt activity App 20080161317 - Kelly; Michael J. ; et al.	2008-07-03
Inhibitors of Akt Activity App 20080009507 - Cosford; Nicholas D.P. ; et al.	2008-01-10
1,3-Disubstituted Heteroaryl Nmda/Nr2b Antagonists App 20070293515 - Layton; Mark E. ; et al.	2007-12-20
4-Cycloakylaminopyrazolo pyrimidine nmda/nr2b antagonists App 20070037829 - Thompson; Wayne ; et al.	2007-02-15
4-Cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists App 20050054658 - Thompson, Wayne ; et al.	2005-03-10
Biomimetic combinatorial synthesis App 20010024798 - Shair, Matthew D. ; et al.	2001-09-27

Company Registrations

SEC

0001687210

Layton Mark E.